The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.

Neeraj NarulaAchuthan AruljothyEmily Chu Lee WongRavi HomenauthAbdul-Aziz AlshahraniJohn K MarshallWalter Reinisch

Published in: United European gastroenterology journal (2021)

Overall, UST did not lead to significant resolution of EIMs for CD compared to placebo at weeks 6 and 52.

Keyphrases